期刊文献+

聚缩酮PCADK的合成及胰岛素微球的制备与表征 被引量:1

Synthesis of polyketal-PCADK and preparation and characterization of insulin microspheres
原文传递
导出
摘要 目的:合成新型生物可降解材料聚缩酮(PCADK),制备胰岛素微球并研究其体外释放行为。方法:以1,4-环己烷二甲醇(CDM)和2,2-二甲氧基丙烷(DMP)为原料合成PCADK,1H NMR表征聚合物结构,凝胶渗透色谱法(GPC)测定聚合物相对分子质量;采用in-situ S/O/W法制备载药微球,HPLC检测计算微球载药量和包封率;并测定了微球在pH=2.0,4.5,7.4的磷酸盐缓冲溶液中的释放行为。结果:重均相对分子质量约为6 500;制备的微球外观圆整,表面有褶皱,载药量为3.90%,包封率达68.0%;体外释放结果显示,聚缩酮微球在酸性条件下降解较快,碱性及中性环境中降解缓慢。结论:新型高分子材料PCADK制备的胰岛素微球,球形好,载药量、包封率较高,体外释放行为显示出pH敏感特性。 Objective: To prepare insulin-loaded microspheres with a novel biodegradable material termed polyketal( PCADK) and evaluate their release behavior in vitro. Methods: The polyketal( PCADK) was synthesized by using 1,4-cyclohexanedimethanol( CDM) and 2,2-dimethoxypropane( DMP). The chemical structure of PCADK was confirmed by 1H NMR and the molecular weights( Mw) of the polymers were determined by gel permeation chromatography( GPC); the microspheres were fabricated through a new solvent evaporation process-in-situ S/O/W process. The drug loading and encapsulation efficiency were detected and calculated via HPLC; the release experiment of microspheres was conducted in phosphate buffer solution( pH = 2. 0,4. 5,7. 4). Results: A polymer with an Mwof approximately 6 500 was obtained; the prepared microspheres had round appearance and plicate surface with drug loading of about 3. 90% and encapsulation efficiency of 68%; the in vitro release experiments showed that the microspheres degraded faster in acid solution than that in alkaline and neutral environment. Conclusion:The microspheres prepared by the novel polymer material-PCADK have high drug loading and encapsulation efficiency as well as pH-sensitive release kinetics.
出处 《中国新药杂志》 CAS CSCD 北大核心 2015年第7期818-822,826,共6页 Chinese Journal of New Drugs
基金 国家重点基础研究发展计划(973计划)(2012CB724003)
关键词 聚缩酮 微球 IN-SITU S/O/W法 胰岛素 体外释放 PH敏感 polyketal microspheres in-situ S/O/W insulin in vitro release pH sensitive
  • 相关文献

参考文献11

  • 1HEFFERNAN MJ, MURTHY N. Polyketal nanoparticles: a newpH-sensitive biodegradable drug delivery vehicle [ J ]. BioconjugChem ,2005,16(6) :1340 - 1342.
  • 2TALUJA A,YOUN YS,BAE YH. Novel approaches in micropar-ticulate PLGA delivery systems encapsulating proteins [J]. J Ma-ter CAem,2007,17(38) :4002 -4014.
  • 3于洪云,陈大全,孙考祥.新型聚缩酮类高分子的合成及其在药物递送系统中的应用[J].中国新药杂志,2013,22(16):1912-1915. 被引量:2
  • 4FIORE VF,LOFTON MC,YANG SC,扣 al Polyketal microparti-cles for therapeutic delivery to the lung[ J]. Biomaterials,2010,31(5) :810-817.
  • 5CHO SK, KWON YJ. Polyamine/DNA polyplexes with acid-de-gradable polymeric shell as structurally and functionally virus-mimicking nonviral vectors [ J ]. J Control Release, 2011,150(3):287 -297.
  • 6MURTHY N, HEFFERNAN MJ,YANG S,e( al. PCADK : a newpolyketal for drug delivery [ J ]. Polym Mat Sci Eng,2007 ,96 :78 -79.
  • 7LEE S, YANG SC, HEFFERNAN M J, et al. Polyketal microparti- cles:a new delivery vehicle for superoxide dismutase[ J]. Biocon- jug Chem,2007 ,18(1) :4 -7.
  • 8BAO WC,ZHOU JX,LUO JF,e( al. PLGA microspheres withhigh drug loading and high encapsulation efficiency prepared by anovel solvent evaporation technique [ J ]. J Microencapsulation,2006,23(5) :471 -479.
  • 9MIYATA T,URAGAMI T,NAKAMAE K. Biomolecule-sensitivehydrogels[ J]. Adv Drug Deliv Rev,2002 ,54(1 ) :79 - 98.
  • 10TAI WY,MO R,DI J, et al. Bio-inspired synthetic nanovesiclesfor glucose-responsive release of insulin[ J]. Biomacromolecules,2014,15(10) :3495 -3502.

二级参考文献21

  • 1孙逊,田聆,聂宇,张志荣,路娇,魏于全.阳离子脂质体-DNA复合物与脂质-鱼精蛋白-DNA复合物体外细胞转染率比较[J].生物医学工程学杂志,2007,24(1):191-195. 被引量:5
  • 2刘红春,王吉耀.甲磺酸伊马替尼对大鼠肝纤维化及转化生长因子-β1表达的影响[J].中华消化杂志,2007,27(6):363-367. 被引量:2
  • 3周芬 程时远.基因治疗中的非病毒载体.化学通报,2005,68(1):1-7.
  • 4YANG SC, CRISPE IN, PIERCE RH, et al. Polyketal Copoly- reefs: a new acid-sensitive delivery vehicle for treating acute in- flamrtlatory diseases [ J ]. Bioconjug Chem, 2008, 19 ( 6 ) : 1164 - 1169.
  • 5SY JC, PHELPS EA, GARCIA AJ, et al. Surface functionaliza- tion of polyketal microparticles with nitrilatriaeetic acid-nlckel complexes for efficient protein capture and deliveryI J]. Biomaterials.2010, 31(18): 4987 -4994.
  • 6LEE S, YANG SC, HEFFERNAN M J, et al. Polyketal microp- articles: a new delivery vehicle for superoxide dismutase [ J ]. Bioconjug Chem, 2007,18( 1 ) :4 -7.
  • 7MURTHY N, HEFFERNAN M, YANG S, et al. PCADK: a new polyketal for drug delivery [ J]. Polym Mat Sci Eng,2007, 96:78 - 79.
  • 8FIORE VF, LOFTON MC, MURTHY N, et al. Polyketal micro- particles for therapeutic delivery to the lung [ J ]. Biomaterials, 2010,31 (5) :810 -817.
  • 9SESHADRI G, BROWN M, DIKALOV S, et al. The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfu- sion injury [ J ]. Biomaterials, 201 O, 31 ( 6 ) : 1372 - 1379.
  • 10SEDER RA, DARRAH PA, ROEDERER M. T-cell quality m memory and protection: implications for vaccine design [ J ]. Nat Rev Immunol, 2008, 8 (4) :247 - 258.

共引文献1

同被引文献29

  • 1李春霖.糖尿病治疗新进展[J].中国药物应用与监测,2007,4(1):1-3. 被引量:9
  • 2俞娉,吴佳丽,傅志泉,李利.金芪降糖片联合格列吡嗪控释片治疗老年糖尿病的临床观察[J].中国中医药科技,2007,14(2):123-124. 被引量:3
  • 3Tan M L, Choong P F M, Dass C R. Recent developments in liposomes, microparticles and nanoparticles for protein andpeptide drug delivery[ J ]. Peptides, 2010,31 ( 1 ) : 184 - 193.
  • 4Sajeesh S,Bouchemal K, Marsaud V. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin[ J ]. Journal of Controlled Release, 2010,147 (3) : 377 - 384.
  • 5Mavridis I M ,Yannakopoulou K. Anionic cyclodextrins as versatile hosts for pharmaceutical nanotechnology : Synthesis, drug delivery, enantioselectivity, contrast agents for M RI[J]. International Journal of Pharmaceutics, 2015,492 (1 -2) : 275 - 290.
  • 6Tan Haina, Qin Fei, Chen Dongfeng. Study of glycol chitosan-carboxymethyl 13 - cyclodextrins as anticancer drugs carrier [J].Carbohydrate Polymers, 2013,93 ( 2 ) : 679 - 685.
  • 7Amancha K P, Balkundi Shantanu, Lvov Yuri. Pulmonary sustained release of insulin from mieroparticles composed of polyelectrolyte layer-by-layer assembly[ J]. International Journal of Pharmaceutics, 2014,466( 1 -2) : 96 -108.
  • 8D6at-Lain6 E, Hoffart Val6rie, Garrait Ghislain. Whey protein and alginate hydrogel microparticles for insulin intestinal absorption: Evaluation of permeability enhancement properties on Caco -2 cells[ J ]. International Journal of Pharmaceuties, 2013,453(2) : 336 -342.
  • 9Zhang Xingwang, Qi Jianping, Lu Yi. Biotinylated liposomes as potential carriers for the oral delivery of insulin. Nanomedicine : Nanotechnology[ J]. Biology and Medicine, 2014,10( 1 ) : 167 - 176.
  • 10Fonte Pedro,Aradjo Francisca,Silva C6tia,et al. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches [J]. Biotechnology Advances, 2015,33(6): 1342-1354.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部